| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |